ZEN-3694 mCRPC trial no longer recruiting

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

ZEN-3694 mCRPC trial no longer recruiting

posted on Apr 30, 2019 05:14PM

A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

https://clinicaltrials.gov/ct2/show/NCT02711956

Updated April 19, 2019.

Active, not recruiting

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply